FDA — authorised 27 September 2022
- Application: BLA761268
- Marketing authorisation holder: CELLTRION
- Local brand name: VEGZELMA
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 VEGZELMA in United States
FDA authorised VEGZELMA on 27 September 2022
Marketing authorisations
FDA
- Status: approved
VEGZELMA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is VEGZELMA approved in United States?
Yes. FDA authorised it on 27 September 2022; FDA has authorised it.
Who is the marketing authorisation holder for VEGZELMA in United States?
CELLTRION holds the US marketing authorisation.